New Anti-Chemokine Oral Drug XC8 in the Treatment of Asthma Patients with Poor Response to Corticosteroids: Results of a Phase 2A Randomized Controlled Clinical Trial.

Romanova, Julia; Chikina, Elena; Rydlovskaya, Anastasia; Pohl, Wolfgang; Renner, Andreas; Zeifman, Alexey; Chuchalin, Alexander; Nebolsin, Vladimir

Romanova, Julia; Chikina, Elena; Rydlovskaya, Anastasia; Pohl, Wolfgang; Renner, Andreas; Zeifman, Alexey; Chuchalin, Alexander; Nebolsin, Vladimir.

Afiliação

Romanova J; EURRUS Biotech GmbH, Tulln, Austria. jr.romanova@gmail.com.
Chikina E; PHARMENTERPRISES LLC, Moscow, Russia.
Rydlovskaya A; PHARMENTERPRISES LLC, Moscow, Russia.
Pohl W; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
Renner A; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
Zeifman A; Chemimmune Therapeutics LLC, Moscow, Russia.
Chuchalin A; Institute of Pulmonology, Federal Medical and Biological Agency, Moscow, Russia.
Nebolsin V; PHARMENTERPRISES LLC, Moscow, Russia.

Pulm Ther ; 6(2): 351-369, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33095411